Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of$ 0.39. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -17.95%. A quarter ago, it was expected that this company would post a loss of$ 0.22 per share when it actually produced a loss of $0.39, delivering a surprise of -77.27%.Over the last four quarters, the company ...